Get Fit Bharat

Tag: Cardio

HomeCardio

October 31, 2024 – Biosergen AB (“Biosergen”), a clinical-stage biotechnology company developing therapies for life-threatening fungal diseases, today announced the completion of treatment for the first cohort of patients in its proof-of-concept clinical trial for its antifungal drug-candidate BSG005. The cohort consisted of five patients: two completely recovered, two saw …

As of 31 October 2024, the total number of shares in Betsson AB (publ) (the “Company”) amounts to 142,729,838 and the total number of votes amounts to 278,035,838. These are divided into 15,034,000 class A shares equaling 150,340,000 votes, 123,448,405 class B shares carrying the same number of votes and …

Press release 31 October 2024 Stendörren Fastigheter AB (publ) (“Stendörren”) announces that Stendörren’s registered number of shares, votes and share capital has increased through the directed share issue of 2,630,208 B shares, corresponding to 2,630,208 votes, which was announced in October 2024. As of 31 October 2024, the total number of registered …

FIDELITY JAPAN TRUST PLC (the 'Company')     TRANSACTION IN OWN SHARES     The Board of the Company announces that it has bought into Treasury     Number of shares repurchased: 23,350 Date of transaction: 31 October 2024 Average share price paid per share (GBp): 154.030 Lowest share price paid per share (GBp): 154.000 …

Atomic Ambitions Expansion Adds Nuclear Power and More STOCKHOLM - 31 October 2024 - The secrets of radioactivity unlock new strategic and development options in Atomic Ambitions, a new expansion for Millennia, the historical 4X strategy game from C Prompt Studios and Paradox Interactive. Power your empire with nuclear plants, …

Nordea Bank AbpStock exchange release – Changes in company’s own shares31.10.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 31.10.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* ** Total cost, EUR* ** XHEL …

Stockholm, Sweden November 1, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: Leqembi) subcutaneous autoinjector for weekly maintenance dosing after …